Related Experiment Video

Updated: May 15, 2025

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

12.1K

Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency

Deborah E Daniels1, Joeseph Hawksworth1, Sara El Hoss2

  • 1School of Biochemistry, University of Bristol, Bristol.

Haematologica
|April 10, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.4K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.6K

Related Experiment Videos

Last Updated: May 15, 2025

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

12.1K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.4K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.6K

Related Concept Videos

CRISPR01:59

CRISPR

48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K

Articles linked to this work by shared authors, journal, and citation graph.

ZEB1 drives terminal erythroid maturation by controlling the GATA2-KLF1 regulatory switch.

Nucleic acids research·2026

IMP1 is a novel posttranscriptional regulator of early erythroid development and embryonic globin output.

Blood advances·2026

Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis.

HemaSphere·2026

MMS22L is a novel key actor of normal and pathological erythropoiesis.

HemaSphere·2025

VEXAS anemia is a mosaic erythroblastopenia.

Blood·2025

Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia.

Haematologica·2024

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Haematologica·2026

Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: "First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level".

Haematologica·2026

Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.

Haematologica·2026

Beyond the Tradition in Tympanoplasty: A Retrospective Cohort Study of a New Modified Palisade Tympanoplasty Technique.

Cureus·2026

Artificial Intelligence as an Assistive Tool in Breast Cancer Screening and Diagnosis in the Digital Era.

International journal of breast cancer·2026

Novel Pyrazoline Derivatives as Therapeutic Candidate for Alzheimer's Disease: An Integrated Network Pharmacology and 3D-QSAR Modelling.

Bioinformatics and biology insights·2026

Orphan GPR84 facilitates uropod de-adhesion at multiple steps during leukocyte extravasation.

EMBO reports·2026

A reactive oxygen species-responsive diclofenac nanogel coating improves the anti-degeneration performance of bioprosthetic heart valves.

Acta biomaterialia·2026

Hydrogen-bond interfacial engineering of silk fibroin-strengthened magnetic colloidal hydrogel for embolization and magnetothermal therapy of hepatocellular carcinoma.

Biomaterials·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us